SPONSOR
Thomas Jefferson University
Total Trials
9
Recruiting
9
Phases
Phase 1, Phase 2, Phase 2, Phase 4
Conditions studied: Metastatic Uveal MelanomaSpinal Cord Injury, ChronicSpinal Cord Injury CervicalSpinal Cord Injury ThoracicIncomplete Spinal Cord InjuryHematologic MalignancyMyelodysplastic SyndromesAcute Myeloid LeukemiaTransfusion Dependent CytopeniasType 2 Diabetes Mellitus (T2DM)
Thomas Jefferson University is a clinical research sponsor with 9 registered studies on ClinicalTrials.gov, of which 9 are actively recruiting participants. Research covers conditions including Metastatic Uveal Melanoma, Spinal Cord Injury, Chronic, Spinal Cord Injury Cervical, Spinal Cord Injury Thoracic.
The trial portfolio spans Phase 1, Phase 2, Phase 2, Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Thomas Jefferson University
How many clinical trials has Thomas Jefferson University sponsored?
ClinicalMetric currently tracks 9 clinical trials sponsored by Thomas Jefferson University, of which 9 are actively recruiting participants. These trials cover conditions including Metastatic Uveal Melanoma, Spinal Cord Injury, Chronic, Spinal Cord Injury Cervical. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Thomas Jefferson University research focus on?
Thomas Jefferson University clinical trials span Metastatic Uveal Melanoma, Spinal Cord Injury, Chronic, Spinal Cord Injury Cervical, Spinal Cord Injury Thoracic, Incomplete Spinal Cord Injury, and additional conditions. The research pipeline includes Phase 1, Phase 2, Phase 2, Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Thomas Jefferson University clinical trial?
To participate in a Thomas Jefferson University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Thomas Jefferson University trials with current recruitment status updated daily.
Clinical Trials by Thomas Jefferson University
NCT06626516 Phase 1, Phase 2
Recruiting
Tebentafusp-tebn With LDT in Metastatic UM
Metastatic Uveal Melanoma
NCT07135583
Recruiting
Non-Invasive Interventions for Respiratory Recovery in Chronic Spinal Cord Injury
Spinal Cord Injury, Chronic
NCT07121140
Recruiting
Home Blood Transfusions
Hematologic Malignancy
NCT07184775
Recruiting
CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes
Type 2 Diabetes Mellitus (T2DM)
NCT06705075 Phase 2
Recruiting
Evaluation of Uterine Fibroids by CEUS and SHAPE Pre and Post UAE
Uterine Fibroid
NCT06826859 Phase 1, Phase 2
Recruiting
Daily Aspirin vs Split Dosing in High-risk Pregnancies (DASH)
Preterm Birth
NCT05775939
Recruiting
PET/CT Imaging to Evaluate Cardiac Radiation Damage in Patients With Lung or Esophageal Cancer, EUCLID Trial
Lung Carcinoma
NCT06419803
Recruiting
Strict Versus Permissive Thresholds for Initiation of Pharmacotherapy in Gestational Diabetes (START 2)
Gestational Diabetes
NCT04278651 Phase 4
Recruiting
Early Antenatal Support for Iron Deficiency Anemia
Pregnancy Related
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology